About Huma
Huma is a company based in London (United Kingdom) founded in 2011. It operates as a AI-as-a-Service, SaaS (Software-as-a-Service), and HealthTech. Huma has raised $354.93 million across 13 funding rounds from investors including Bayer, Astrazeneca and Sony Innovation Fund. Huma has completed 8 acquisitions, including Alcedis, Aluna and Amaze Health. Huma offers products and services including Huma Cloud Platform (HCP), Huma Intelligence (Hi), Hi Scribe, and Hi Nurse.
- Headquarter London, United Kingdom
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Huma Therapeutics Limited
- Date of Incorporation 02 Aug, 2011
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
$15.69 M (USD)139as on Dec 31, 2022
-
Net Profit
-$38.25 M (USD)-20as on Dec 31, 2022
-
EBITDA
-$39.21 M (USD)-15as on Dec 31, 2022
-
Total Equity Funding
$354.93 M (USD)
in 13 rounds
-
Latest Funding Round
$17.29 M (USD), Series D
Apr 25, 2025
-
Investors
Bayer
& 9 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Alcedis
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Huma
Huma offers a comprehensive portfolio of products and services, including Huma Cloud Platform (HCP), Huma Intelligence (Hi), Hi Scribe, and Hi Nurse.
A foundation for digital health innovation is provided.
AI tools for healthcare transformation are being developed.
Clinical and billing information capture is automated efficiently.
Clinical productivity for nurses is significantly enhanced here.
People of Huma
Unlock access to complete
Unlock access to complete
Funding Insights of Huma
Huma has successfully raised a total of $354.93M across 13 strategic funding rounds. The most recent funding activity was a Series D round of $17.29 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Series D — $17.3M
-
First Round
First Round
(11 Oct 2013)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series D - Huma | Valuation |
investors |
|
| Mar, 2025 | Amount | Series D - Huma | Valuation |
investors |
|
| Sep, 2024 | Amount | Series D - Huma | Valuation |
investors |
|
Investors in Huma
Huma has secured backing from 10 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Bayer, Astrazeneca and Sony Innovation Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and infrastructure investments are focused on multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided for technology and healthcare companies.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences sector
|
Founded Year | Domain | Location |
Investments & Acquisitions by Huma
Huma has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Alcedis, Aluna and Amaze Health.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Smart devices and apps for children's asthma tracking are provided.
|
2020 | ||||
|
Teleconsultation solutions are provided for employee healthcare access.
|
2017 | ||||
|
Patient data from wearables and sensors is analyzed and measured.
|
2014 |
Financial Statements - Huma
Huma Comparisons
Competitors of Huma
Latest news on Huma
Frequently Asked Questions about Huma
Huma was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Huma is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Huma is a funded company, having raised a total of $354.93M across 13 funding rounds to date. The company's 1st funding round was a Series D of $18.77M, raised on Oct 11, 2013.
Annual revenue of Huma is $15.69M as on Dec 31, 2022.
Digital and AI-first health solutions are offered by Huma, focusing on transforming healthcare through innovative technology. Products like Huma Cloud Platform, Huma Intelligence, and specific tools such as Hi Scribe and Hi Nurse are provided to enhance clinical productivity and automate documentation. The company operates in sectors including regulated digital health, life sciences, and global health systems. Solutions span remote patient monitoring, virtual wards, hospital-at-home models, AI-driven diagnostics, and clinical trial data capture. A worldwide impact is achieved, supporting nearly 100 million people across multiple continents with regulatory compliance.
Huma offers Huma Cloud Platform (HCP), Huma Intelligence (Hi), Hi Scribe, and Hi Nurse.
Huma has made 8 acquisitions, including Alcedis, Aluna, and Amaze Health.
Huma has 10 investors. Key investors include Bayer, Astrazeneca, Sony Innovation Fund, HAT, and Hitachi Ventures.
The valuation of Huma is $592.87M as of Mar 2022.